BioCentury
ARTICLE | Financial News

NGM raises $50 million in series C

July 19, 2013 12:18 AM UTC

NGM Biopharmaceuticals Inc. (South San Francisco, Calif.) raised $50 million in a series C round from new investor Topspin Fund and existing investors The Column Group; Prospect Venture Partners; Rho ...